Thalomid and Paraparesis - a phase IV clinical study of FDA data

Summary:

Paraparesis is reported as a side effect among people who take Thalomid (thalidomide), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Coumadin, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Paraparesis when taking Thalomid. It is created by eHealthMe based on reports of 38,055 people who have side effects when taking Thalomid from the FDA, and is updated regularly.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.

What is Paraparesis?

Paraparesis (partial paralysis of the lower limbs) is found to be associated with 276 drugs and 414 conditions by eHealthMe. Check the latest studies of Paraparesis.

On Jul, 14, 2026

38,055 people reported to have side effects when taking Thalomid.
Among them, 11 people (0.03%) have Paraparesis.

Among these 11 people:

How long have people been on Thalomid when they have Paraparesis? *

What is the gender of people who have Paraparesis when taking Thalomid? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Paraparesis when taking Thalomid? *

What are other drugs people take besides Thalomid? *

What are other side effects people have besides Paraparesis? *

Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 11 people, 100.00%
Wound Dehiscence (a surgical incision reopens either internally or externally): 10 people, 90.91%
Osteomyelitis Chronic (long lasting infection of bone marrow): 10 people, 90.91%
Neuropathy Peripheral (surface nerve damage): 10 people, 90.91%
Nervousness: 10 people, 90.91%
Monocytosis (an increase in the number of monocytes circulating in the blood): 10 people, 90.91%
Mitral Valve Incompetence (inefficient heart valve): 10 people, 90.91%
Metastases To Liver (cancer spreads to liver): 10 people, 90.91%
Leriche Syndrome (decreased pulses in the lower limbs): 10 people, 90.91%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 10 people, 90.91%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Thalomid and have Paraparesis?

- Check whether Paraparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalomid:

Thalomid (38,099 reports)

Paraparesis treatments and more:

Paraparesis (2,507 reports)

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraparesis:

Paraparesis (276 drugs)

Browse all the conditions that are associated with Paraparesis:

Paraparesis (414 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalomid) and Thalomid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.